Page 2 - Flipbook
P. 2
Moderator
Peter Black
Urologic Oncologist, Vancouver General Hospital
Research Scientist, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia
Disclosures:
Advisory Boards: AbbVie, Asieris, AstraZeneca, Astellas, Bayer, Biosyent, BMS, EMD-Serono, Ferring, Fergene,
H3-Biomedicine, Janssen, Merck, Roche, Sanofi, Urogen, Protara Therapeutics
Speakers Bureau: AbbVie, Biosyent, Janssen, Ferring, TerSera, Pfizer
Payment: Sanofi, Bayer
Grant/Honorarium: iProgen
Product Patent: Decipher Biosciences
Clinical Trial: Genentech, Janssen, BMS, Astellas, MDx Health, AstraZeneca, Therelase, Pacific Edge
Leadership/Board Position: 1. IBCN (General Secretary) 2. Western Section AUA (Alternate Board Member)
